Kayyem Jon Faiz

Average Profitability
22.69%
Insider Buys Quantity
4
Insider Buys Sum
$1.36M
Insider Sells Quantity
4
Insider Sells Sum
$1.07M

Insider Activity of Kayyem Jon Faiz

According to the SEC Form 4 filings, Kayyem Jon Faiz, being in a position of

  1. director at Inhibrx Biosciences, Inc.,
    оver the last 12 months, has bought 53593 shares for $761,810, and sold 0 shares,
    over all time since 2022-10-21, has bought 53593 shares for $761,810, and sold 38000 shares for $1.07M.

The largest purchase of all time was on 2024-11-19 and amounted to 34843 shares of Inhibrx Biosciences, Inc. for $495,708.

The largest sale of all time was on 2022-10-21 and amounted to 9500 shares of Inhibrx Biosciences, Inc. for $286,232.

Biography of Kayyem Jon Faiz

No biography is available at this moment.

2024-11-20PurchaseInhibrx Biosciences, Inc.
INBX
director
18,750
0.1292%
$14.19$266,102-0.43%
2024-11-19PurchaseInhibrx Biosciences, Inc.
INBX
director
34,843
0.2402%
$14.23$495,708-0.21%
2023-01-23SaleInhibrx, Inc.
INBX
director
9,500
0.0235%
$25.26$239,999-10.09%
2022-12-21SaleInhibrx, Inc.
INBX
director
9,500
0.0222%
$27.02$256,679-14.55%
2022-11-21PurchaseBiodesix, Inc.
BDSX
director
173,913
0.2661%
$1.15$200,000+22.69%
2022-11-21PurchaseBiodesix, Inc.
BDSX
director
347,826
0.5323%
$1.15$400,000+22.69%
2022-11-21SaleInhibrx, Inc.
INBX
director
9,500
0.0217%
$29.89$283,972-23.82%
2022-10-21SaleInhibrx, Inc.
INBX
director
9,500
0.0213%
$30.13$286,232-23.68%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.